Q/C Technologies (QCLS) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
VolitionRX is the larger company by market cap ($6.7 million vs $4.9 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QCLS | VNRX |
|---|---|---|
| Share price | $0.6015 | $0.2226 |
| Market cap | $4.93M | $6.69M |
| 1-day change | -5.53% | +1.46% |
| P/E ratio (TTM) | 0.23 | — |
| EPS (TTM) | $2.62 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.17 | $10.40 |
| 52-week low | $0.42 | $0.22 |
| Distance from 52-week high | -92.64% | -97.86% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +6018.60% |
| Average volume | 4.98M | 8.47M |
| Shares outstanding | 8.19M | 30.06M |
| Employees | 3 | 57 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Q/C Technologies
QCLS stock →Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 3 employees
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 57 employees
QCLS vs VNRX FAQ
Which is bigger, Q/C Technologies or VolitionRX?
VolitionRX (VNRX) is larger, with a market capitalization of $6.69M compared with $4.93M for Q/C Technologies (QCLS).
Are Q/C Technologies and VolitionRX in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.